Novocure Receives IDE Approval to Initiate METIS Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/12/2026

1. CRWV
2. RKLB
3. ONON
4. ACVA
5. SPY
6. RIOT
7. RPD
8. NVDA
9. HIMS
10. FERG

Go back to Novocure Receives IDE Approval to Initiate METIS Trial
(NASDAQ: NVCR) Delayed: 17.66 --0 (-0%)
Previous Close $17.66    52 Week High $28.95 
Open $17.66    52 Week Low $5.95 
Day High $17.66    P/E N/A 
Day Low $17.66    EPS $0.00 
Volume 5